Related Articles
[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 <em>in vitro</em> and <em>in vivo</em>
Potent anti-metastatic activity of combretastatin-A4
Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro
Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer
BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells